Key microRNAs in the biology of breast cancer; emerging evidence in the last decade.
biology
breast cancer (BC)
dysregulation
microRNAs (miRNAs)
target
Journal
Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
18
07
2018
accepted:
16
10
2018
pubmed:
14
11
2018
medline:
9
4
2020
entrez:
14
11
2018
Statut:
ppublish
Résumé
microRNAs (miRNAs) are a family of small noncoding RNAs that play a pivotal role in the regulation of main biological and physiological processes, including cell cycle regulation, proliferation, differentiation, apoptosis, stem cell maintenance, and organ development. Dysregulation of these tiny molecules has been related to different human diseases, such as cancer. It has been estimated that more than 50% of these noncoding RNA sequences are placed on fragile sites or cancer-associated genomic regions. After the discovery of the first specific miRNA signatures in breast cancer, many studies focused on the involvement of these small RNAs in the pathophysiology of breast tumors and their possible clinical implications as reliable prognostic biomarkers or as a new therapeutic approach. Therefore, the present review will focus on the recent findings on the involvement of miRNAs in the biology of breast cancer associated with their clinical implications.
Substances chimiques
MicroRNAs
0
RNA, Untranslated
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
8316-8326Informations de copyright
© 2018 Wiley Periodicals, Inc.